Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

557 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.
Vlassara H, Bucala R, Striker L. Vlassara H, et al. Among authors: bucala r. Lab Invest. 1994 Feb;70(2):138-51. Lab Invest. 1994. PMID: 8139257 Review. No abstract available.
Characterization of a novel hemoglobin-glutathione adduct that is elevated in diabetic patients.
Al-Abed Y, VanPatten S, Li H, Lawson JA, FitzGerald GA, Manogue KR, Bucala R. Al-Abed Y, et al. Among authors: bucala r. Mol Med. 2001 Sep;7(9):619-23. Mol Med. 2001. PMID: 11778651 Free PMC article.
Immunological detection of fructose-derived advanced glycation end-products.
Takeuchi M, Iwaki M, Takino J, Shirai H, Kawakami M, Bucala R, Yamagishi S. Takeuchi M, et al. Among authors: bucala r. Lab Invest. 2010 Jul;90(7):1117-27. doi: 10.1038/labinvest.2010.62. Epub 2010 Mar 8. Lab Invest. 2010. PMID: 20212455
Diabetes, aging, and their tissue complications.
Bucala R. Bucala R. J Clin Invest. 2014 May;124(5):1887-8. doi: 10.1172/JCI75224. Epub 2014 May 1. J Clin Invest. 2014. PMID: 24789881 Free PMC article. Review.
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.
Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H. Stitt AW, et al. Among authors: bucala r. Am J Pathol. 1997 Feb;150(2):523-31. Am J Pathol. 1997. PMID: 9033268 Free PMC article.
Structure of a synthetic glucose derived advanced glycation end product that is immunologically cross-reactive with its naturally occurring counterparts.
Al-Abed Y, Bucala R. Al-Abed Y, et al. Among authors: bucala r. Bioconjug Chem. 2000 Jan-Feb;11(1):39-45. doi: 10.1021/bc990061q. Bioconjug Chem. 2000. PMID: 10639083
Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in uremia.
Fishbane S, Bucala R, Pereira BJ, Founds H, Vlassara H. Fishbane S, et al. Among authors: bucala r. Kidney Int. 1997 Dec;52(6):1645-50. doi: 10.1038/ki.1997.497. Kidney Int. 1997. PMID: 9407512 Clinical Trial.
What is the effect of hyperglycemia on atherogenesis and can it be reversed by aminoguanidine?
Bucala R. Bucala R. Diabetes Res Clin Pract. 1996 Feb;30 Suppl:123-30. doi: 10.1016/s0168-8227(96)80048-9. Diabetes Res Clin Pract. 1996. PMID: 8964186 Review.
Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers.
Nicholl ID, Stitt AW, Moore JE, Ritchie AJ, Archer DB, Bucala R. Nicholl ID, et al. Among authors: bucala r. Mol Med. 1998 Sep;4(9):594-601. Mol Med. 1998. PMID: 9848076 Free PMC article.
Inhibition of advanced glycation endproduct formation by acetaldehyde: role in the cardioprotective effect of ethanol.
Al-Abed Y, Mitsuhashi T, Li H, Lawson JA, FitzGerald GA, Founds H, Donnelly T, Cerami A, Ulrich P, Bucala R. Al-Abed Y, et al. Among authors: bucala r. Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2385-90. doi: 10.1073/pnas.96.5.2385. Proc Natl Acad Sci U S A. 1999. PMID: 10051651 Free PMC article.
557 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page